Atossa Therapeutics Inc (ATOS)
0.7119 x 3 0.7197 x 53
Post-market by (Cboe BZX)
0.7197 +0.0297 (+4.30%) 03/14/25 [NASDAQ]
0.7119 x 3 0.7197 x 53
Post-market 0.7197 unch (unch) 16:02 ET
for Fri, Mar 14th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 6,385 | 7,105 | 6,980 | 9,018 | 7,468 |
| Operating Income | -6,385 | -7,105 | -6,980 | -9,018 | -7,468 |
| Other Income | -845 | 1,056 | 1,102 | 1,264 | 1,239 |
| Pre-tax Income | -7,230 | -6,049 | -5,878 | -7,754 | -6,229 |
| Net Income Continuous | -7,230 | -6,049 | -5,878 | -7,754 | -6,229 |
| Net Income | $-7,230 | $-6,049 | $-5,878 | $-7,754 | $-6,229 |
| EPS Basic Total Ops | -0.06 | -0.05 | -0.05 | -0.06 | -0.05 |
| EPS Basic Continuous Ops | -0.06 | -0.05 | -0.05 | -0.06 | -0.05 |
| EPS Diluted Total Ops | -0.06 | -0.05 | -0.05 | -0.06 | -0.05 |
| EPS Diluted Continuous Ops | -0.06 | -0.05 | -0.05 | -0.06 | -0.05 |
| EPS Diluted Before Non-Recurring Items | -0.05 | -0.05 | -0.05 | -0.06 | -0.05 |
| EBITDA(a) | $-6,381 | $-7,101 | $-6,975 | $-9,004 | $-7,465 |